이경원 프로필 사진

이경원

Lee, Gyeong Won

의과대학

의학과

Scopus ORCID

자료 필터

자료유형

발행연도

2004 ~ 2026
2004 2026

키워드

언어

선택된 필터

  • article
  • conference
  • book

전체 240건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies

  • Kim, J. W. ; 
  • Park, Y. H. ; 
  • Lee, S. ; 
  • Ahn, H. K. ; 
  • Bae, J. ; 
  • ... Lee, G. W. ; 
  • 외 23명
  • 2026-07
  • ESMO Open
  • BMJ PUBLISHING GROUP
Article

Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera

  • 이지윤 ; 
  • 윤성수 ; 
  • 양덕환 ; 
  • 손상균 ; 
  • 윤석윤 ; 
  • ... 이경원 ; 
  • 외 6명
  • 2026-07
  • Cancer Research and Treatment
  • 대한암학회
Article

A phase 2 multicenter, open-label, parallel cohort study to evaluate the efficacy, safety, and pharmacokinetic profile of ABN401 in patients with advanced solid tumors harboring c-MET dysregulation

  • Le, Xiuning ; 
  • Kim, Hye Ryun ; 
  • Lee, Dae Ho ; 
  • Lee, Se-Hoon ; 
  • Lee, Ki Hyeong ; 
  • ... Lee, Gyeong-won ; 
  • 외 4명
  • 2026-06
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

SPECTRUM: Phase II study of tislelizumab plus pemetrexed in patients with relapsed or refractory (R/R) primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS)-The Korean Cancer Study Group LY22-07.

  • Kim, Jung Sun ; 
  • Lee, Gyeong-Won ; 
  • Lee, Myungwon ; 
  • Youk, Jeonghwan ; 
  • Lee, Hyunjung ; 
  • 외 5명
  • 2026-06
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancers

  • Lee, Jiwon ; 
  • Sim, Jongmin ; 
  • Lee, Yun-Gyoo ; 
  • Lee, Gyeong-Won ; 
  • Jung, Hyun Ae ; 
  • 외 13명
  • 2026-06
  • International Journal of Clinical Oncology
  • SPRINGER JAPAN KK
Article

Global Phase 2 Randomized Trial of Pumitamig (BNT327/BMS986545; PD-L1 x VEGF-A bsAb) plus Chemotherapy for 1L ES-SCLC: Dose Optimization Analysis

  • Heymach, J., V ; 
  • Cho, B. C. ; 
  • Sezer, A. ; 
  • Karacin, C. ; 
  • Lee, Y. ; 
  • ... Lee, G. - W. ; 
  • 외 23명
  • 2026-05
  • Journal of Thoracic Oncology
  • ELSEVIER SCIENCE INC
Article

A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24)

  • Kim, Miso ; 
  • Youk, Jeonghwan ; 
  • Kim, Tae Min ; 
  • Lee, Gyeong-Won ; 
  • Kim, Dong-Wan ; 
  • 외 1명
  • 2026-04
  • Clinical Lung Cancer
  • Cancer Information Group
Article

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study

  • Lee, Jung Yeon ; 
  • Choi, Suein ; 
  • Jung, Seungpil ; 
  • Park, Sung-Soo ; 
  • Kim, Jin Seok ; 
  • ... Lee, Gyeong-Won ; 
  • 외 10명
  • 2026-03
  • Annals of Hematology
  • Springer Verlag
Article

Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials

  • Kim, Dong Hyun ; 
  • Kim, Miso ; 
  • Youk, Jeonghwan ; 
  • Kim, Tae Min ; 
  • Lee, Gyeong-Won ; 
  • 외 9명
  • 2026-03
  • Lung Cancer
  • Elsevier BV
Article

Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b

  • Yoon, Seug Yun ; 
  • Yoon, Sung-Soo ; 
  • Yang, Deok-Hwan ; 
  • Lee, Gyeong-Won ; 
  • Sohn, Sang Kyun ; 
  • 외 10명
  • 2026-03
  • Therapeutic Advances in Hematology
  • 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP
12345 끝